Orchestra BioMed Holdings, Inc. (OBIO)

Orchestra BioMed Holdings Statistics

Total Valuation

OBIO has a market cap or net worth of $106.51 million. The enterprise value is $56.23 million.

Market Cap	106.51M
Enterprise Value	56.23M

Important Dates

The next estimated earnings date is Monday, May 12, 2025, after market close.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

OBIO has 38.31 million shares outstanding. The number of shares has increased by 10.82% in one year.

Current Share Class	38.31M
Shares Outstanding	38.31M
Shares Change (YoY)	+10.82%
Shares Change (QoQ)	+1.18%
Owned by Insiders (%)	3.29%
Owned by Institutions (%)	21.62%
Float	18.39M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	38.80
Forward PS	31.03
PB Ratio	3.22
P/TBV Ratio	3.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	21.31
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.27, with a Debt / Equity ratio of 0.50.

Current Ratio	4.27
Quick Ratio	4.13
Debt / Equity	0.50
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-216.50

Financial Efficiency

Return on equity (ROE) is -120.84% and return on invested capital (ROIC) is -67.42%.

Return on Equity (ROE)	-120.84%
Return on Assets (ROA)	-46.90%
Return on Invested Capital (ROIC)	-67.42%
Return on Capital Employed (ROCE)	-107.23%
Revenue Per Employee	$37,686
Profits Per Employee	-$871,771
Employee Count	70
Asset Turnover	0.03
Inventory Turnover	1.28

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.95% in the last 52 weeks. The beta is 0.62, so OBIO's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	-37.95%
50-Day Moving Average	3.94
200-Day Moving Average	5.33
Relative Strength Index (RSI)	38.49
Average Volume (20 Days)	826,414

Short Selling Information

The latest short interest is 541,410, so 1.41% of the outstanding shares have been sold short.

Short Interest	541,410
Short Previous Month	572,290
Short % of Shares Out	1.41%
Short % of Float	2.94%
Short Ratio (days to cover)	8.21

Income Statement

In the last 12 months, OBIO had revenue of $2.64 million and -$61.02 million in losses. Loss per share was -$1.66.

Revenue	2.64M
Gross Profit	2.43M
Operating Income	-64.30M
Pretax Income	-51.64M
Net Income	-61.02M
EBITDA	-63.99M
EBIT	-64.30M
Loss Per Share	-$1.66

Balance Sheet

The company has $66.81 million in cash and $16.53 million in debt, giving a net cash position of $50.28 million or $1.31 per share.

Cash & Cash Equivalents	66.81M
Total Debt	16.53M
Net Cash	50.28M
Net Cash Per Share	$1.31
Equity (Book Value)	32.96M
Book Value Per Share	0.86
Working Capital	52.96M

Cash Flow

In the last 12 months, operating cash flow was -$50.56 million and capital expenditures -$289,000, giving a free cash flow of -$50.85 million.

Operating Cash Flow	-50.56M
Capital Expenditures	-289,000
Free Cash Flow	-50.85M
FCF Per Share	-$1.33

Margins

Gross Margin	92.27%
Operating Margin	-2,437.49%
Pretax Margin	-2,313.27%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.82%
Shareholder Yield	n/a
Earnings Yield	-57.29%
FCF Yield	-47.74%

Analyst Forecast

The average price target for OBIO is $15.00, which is 439.57% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.00
Price Target Difference	439.57%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	85.17%
EPS Growth Forecast (5Y)	-20.53%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

OBIO has an Altman Z-Score of -4.51 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.51
Piotroski F-Score	2